Please read and agree to the
terms and conditions
of this site.
I agree
Funding Series
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
cancer
clinical trials
financing
2
×
funding
life sciences
national blog main
orbimed
2
×
seattle blog main
venture capital
abbvie
acerta pharma
adage capital management
adverse events
alexandria venture investments
antibody drugs
antibody-drug conjugate
arix
arix bioscience
astrazeneca
bispecific antibodies
bristol meyers squibb
calistoga pharmaceuticals
celgene
citadel
clayton knox
colt ventures
cormorant asset management
dave johnson
decheng capital
drug conjugates
farallon
foresite capital
funds and accounts advised by t. rowe price associates
gilead sciences
her2
her2 positive
human epidermal growth factor
hunt investment group
immunotherapy
What
cancer
2
×
drug
targeting
years
adds
advance
antibody
avoid
based
biotech
ceo
dangerous
dave
developing
diego
drugs
effects
immunotherapies
johnson
kept
kipps
known
nearly
physician
reseacher
ror
san
silverback
tacks
test
therapeutics
thomas
tumor
uc
velosbio
Language
unset
Current search:
cancer
×
financing
×
orbimed
×
photo
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}